Evidence map›Paper›PMID 25257900›Full record

ReviewMembranes2014

Trafficking of ThermoTRP Channels.

Clotilde Ferrandiz-Huertas, Sakthikumar Mathivanan, Christoph Jakob Wolf, Isabel Devesa, Antonio Ferrer-Montiel

Abstract readReview
In one paragraph

Review in Membranes, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. Trial
  2. Article
  3. Roles of TRPM channels in glioma.Cancer biology & therapy · 2024
    Review
  4. Review
  5. Review
  6. Article
  7. The odyssey of the TR(i)P journey to the cellular membrane.Frontiers in cell and developmental biology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. OnabotulinumtoxinA effects on trigeminal nociceptors.Cephalalgia : an international journal of headache · 2023
    Article
  14. Article
  15. Review
  16. A journey from molecule to physiology andFrontiers in pharmacology · 2023
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Clotilde Ferrandiz-HuertasInstituto de Biología Molecular y Celular, Universidad Miguel Hernández, Alicante 03202, Spain. clotilde.ferrandiz@umh.es.
Sakthikumar MathivananInstituto de Biología Molecular y Celular, Universidad Miguel Hernández, Alicante 03202, Spain. smathivanan@umh.es.
Christoph Jakob WolfInstituto de Biología Molecular y Celular, Universidad Miguel Hernández, Alicante 03202, Spain. cwolf@umh.es.
Isabel DevesaInstituto de Biología Molecular y Celular, Universidad Miguel Hernández, Alicante 03202, Spain. idevesa@umh.es.
Antonio Ferrer-MontielInstituto de Biología Molecular y Celular, Universidad Miguel Hernández, Alicante 03202, Spain. aferrer@umh.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ThermoTRP channels (thermoTRPs) define a subfamily of the transient receptor potential (TRP) channels that are activated by changes in the environmental temperature, from noxious cold to injurious heat. Acting as integrators of several stimuli and signalling pathways, dysfunction of these channels contributes to several pathological states. The surface expression of thermoTRPs is controlled by both, the constitutive and regulated vesicular trafficking. Modulation of receptor surface density during pathological processes is nowadays considered as an interesting therapeutic approach for management of diseases, such as chronic pain, in which an increased trafficking is associated with the pathological state. This review will focus on the recent advances trafficking of the thermoTRP channels, TRPV1, TRPV2, TRPV4, TRPM3, TRPM8 and TRPA1, into/from the plasma membrane. Particularly, regulated membrane insertion of thermoTRPs channels contributes to a fine tuning of final channel activity, and indeed, it has resulted in the development of novel therapeutic approaches with successful clinical results such as disruption of SNARE-dependent exocytosis by botulinum toxin or botulinomimetic peptides.

Identifiers

PMID25257900
PMCPMC4194048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.